bloodwork
Home
Biomarkers
Categories
Panels
Conditions
Reference
LOINC parts
72,372 parts · page 317 of 1,448 ·
all codes
Part
Name
Type
Tests
LP173695-0
Actual route of administration - attempted or completed
COMPONENT
1
LP173696-8
Patient safety event report - hospital - medication or other substance - version 1.2
COMPONENT
1
LP173697-6
Brand name - RxNorm RXCUI
COMPONENT
1
LP173698-4
Ingredient - RxNorm RXCUI
COMPONENT
1
LP17370-5
Cornish hen
COMPONENT
LP173700-8
Agency for Healthcare Research and Quality (AHRQ) survey panels
CLASS
LP173701-6
Medication or other substance details panel
COMPONENT
1
LP173702-4
Medication or substance was
COMPONENT
LP173703-2
Brand name
COMPONENT
1
LP173704-0
Patient safety event
COMPONENT
1
LP173705-7
P504S Ag
COMPONENT
1
LP173706-5
PDGFR-alpha Ag
COMPONENT
1
LP173707-3
Perforin Ag
COMPONENT
1
LP173708-1
Ubiquitin Ag
COMPONENT
1
LP173709-9
Phospho-S6 ribosomal protein Ag
COMPONENT
1
LP17371-3
Cotton gin dust
COMPONENT
LP173710-7
Pemptoporphyrin
COMPONENT
1
LP173712-3
Nitrogen panel
COMPONENT
1
LP173713-1
GABA free and total panel
COMPONENT
1
LP173714-9
Medium-chain Acyl CoA dehydrogenase
COMPONENT
2
LP173716-4
Sugars and polyols pattern
COMPONENT
1
LP173717-2
Desmosterol
COMPONENT
2
LP173718-0
Lanosterol
COMPONENT
1
LP173719-8
Stigmasterol
COMPONENT
2
LP17372-1
Cotton linters
COMPONENT
LP173720-6
Beta sitosterol
COMPONENT
2
LP173721-4
Stigmastanol
COMPONENT
1
LP173722-2
Sugar absorption test panel
COMPONENT
1
LP173723-0
Tryptophan, kynurenin and 3-hydroxykynurenin panel
COMPONENT
1
LP173724-8
Sugars and polyols panel
COMPONENT
1
LP173725-5
3-Hydroxykynurenin
COMPONENT
2
LP173727-1
Sterols panel
COMPONENT
2
LP173728-9
ADHD action plan
COMPONENT
1
LP173729-7
Autism action plan
COMPONENT
1
LP173730-5
Seizure Disorder action plan
COMPONENT
1
LP173731-3
Anaphylaxis action plan
COMPONENT
1
LP173732-1
Diabetes Type II action plan
COMPONENT
1
LP173733-9
Diabetes Type I action plan
COMPONENT
1
LP173734-7
Inflammatory bowel disease action plan
COMPONENT
1
LP173735-4
Cystic fibrosis action plan
COMPONENT
1
LP173736-2
Muscular Dystrophy action plan
COMPONENT
1
LP173737-0
Heart disease action plan
COMPONENT
1
LP173738-8
Multiple sclerosis action plan
COMPONENT
1
LP173739-6
Complex medical conditions action plan
COMPONENT
1
LP17374-7
Western Cottonwood (Populus fremontii)
COMPONENT
LP173752-9
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA
COMPONENT
14
LP173753-7
Middle East respiratory syndrome coronavirus (MERS-CoV)
COMPONENT
1
LP173754-5
ADHD action plan
Document.Kind
1
LP173755-2
Anaphylaxis action plan
Document.Kind
1
LP173756-0
Asthma action plan
Document.Kind
1
← prev
·
next →